New MHRA service to support medicines innovation and strengthen UK manufacturing  

Imported from official source

Alert

Safety Classified by Officially

Companies developing new technologies to make medicines, including personalised treatments made at or near hospitals and clinics, manufacturing in space, and the use of AI, robotics and automation, are set to receive earlier practical support from the Medicines and Healthcare products Regulatory Agency (MHRA) to help promising technologies reach patients sooner. 

The MHRA has secured funding from the Office for Life Sciences (OLS) to develop and test AdvanceGxP, announced by Science, Innovation and Investment Minister Chris McDonald MP in his closing speech at the inaugural DIA-MHRA Global Summit in London yesterday (17 November) as part of London Life Sciences Week.  

Initially focusing on advanced manufacturing technologies, AdvanceGxP is being developed by the MHRA to help innovators address regulatory and quality questions earlier, reducing the risk of avoidable redesign and delays, and supporting more sustainable approaches. 

The approach is intended to support patient access to new treatments and strengthen UK manufacturing, supporting the Government’s Life Sciences Sector Plan and wider Industrial Strategy. 

Science, Innovation and Investment Minister Chris McDonald MP, said: 

MHRA Chief Executive, Lawrence Tallon, said: 

“We want the UK to be a place where the next generation of innovative medicines can be developed and made. Giving developers practical support earlier can help solve problems before they cause delays, build confidence to invest and make it easier for promising new approaches to grow and scale here.  

“Ultimately, this is about creating the right environment for promising new approaches to become a reality and helping innovative treatments reach patients sooner.” 

This is an extract. The publication continues at the source.

Contains public sector information licensed under the Open Government Licence v3.0. Licence

Read the original at the source: https://www.gov.uk/government/news/new-mhra-service-to-support-medicines-innovation-and-strengthen-uk-manufacturing

Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Medicines and Healthcare products Regulatory Agency — imported from official source
Official source
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
Imported
November 18, 2026 10:00
Versions
1 recorded
Identity
https://www.gov.uk/government/news/new-mhra-service-to-support-medicines-innovation-and...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.